RLL
Lutherville, US · Delaware LLC
Founders & leadership
JT
JONATHAN THOMASExecutive
LS
LAUREN SCHNAPERNamed on SEC filing
Board
RH
ROBERT HICKEYBoard director
LM
LINDA MALKASBoard director
MB
MICHAEL BRINKENHOFFBoard director
Reported raises · per SEC filings
Form D private placements$12.7M disclosed across 5 of 7 rounds · 2018–2026
▶$2MraisedApr 2026 · 11 investors · BiotechnologyRule 506(b)
▶$2MraisedApr 2026 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ROBERT HICKEYDirector
- LAUREN SCHNAPERExecutive Officer, Director, Promoter
- LINDA MALKASDirector
- MICHAEL BRINKENHOFFDirector
- JONATHAN THOMASExecutive Officer
- Amount sold
- $2M
- First sale
- Apr 2026
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedJun 2025 · BiotechnologyRule 506(b)
▶Undisclosed amountofferedJun 2025 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ROBERT HICKEYDirector
- LINDA MALKASDirector
- JONATHAN THOMASExecutive Officer
- MICHAEL BRINKENHOFFDirector
- LAUREN SCHNAPERExecutive Officer, Director, Promoter
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedDec 2024 · BiotechnologyRule 506(b)
▶Undisclosed amountofferedDec 2024 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ROBERT HICKEYDirector
- LINDA MALKASDirector
- LAUREN SCHNAPERExecutive Officer, Director, Promoter
- JONATHAN THOMASExecutive Officer
- MICHAEL BRINKENHOFFDirector
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$8MraisedJul 2021 · 17 investors · BiotechnologyRule 506(b)
▶$8MraisedJul 2021 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ROBERT HICKEYDirector
- LINDA MALKASDirector
- LAUREN SCHNAPERExecutive Officer, Director, Promoter
- JONATHAN THOMASExecutive Officer
- MICHAEL BRINKENHOFFDirector
- Amount sold
- $8M
- Proceeds to insiders
- $221.3K
- First sale
- Jul 2021
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedFeb 2020 · 2 investors · BiotechnologyRule 506(b)
▶$1.5MraisedFeb 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- LAUREN SCHNAPERExecutive Officer, Director, Promoter
- ROBERT HICKEYDirector
- LINDA MALKASDirector
- Offering amount
- $2.6M
- Amount sold
- $1.5M
- First sale
- Feb 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$500KraisedApr 2019 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedApr 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- LAUREN SCHNAPERExecutive Officer, Director, Promoter
- LINDA MALKASDirector
- ROBERT HICKEYDirector
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- Mar 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$684.2KraisedOct 2018 · 1 investors · BiotechnologyRule 506(b)
▶$684.2KraisedOct 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- LINDA MALKASDirector
- LAUREN SCHNAPERExecutive Officer, Director, Promoter
- ROBERT HICKEYDirector
- Amount sold
- $684.2K
- First sale
- Sep 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has RLL raised?
- RLL has disclosed $12.7M raised across 5 of its 7 known rounds.
- Where is RLL headquartered?
- RLL is headquartered in Lutherville, US.